Filing
3rd Quarter - Report
Bills named in this filing
1
Lobbying activity
1
Issues related to the 340B drug discount program. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169) and H.R.1, FY25 budget reconciliation.